Abstract:Zhihua Zhang, 1 Yuhong Wang, 2 Yankun Zhang, 3 Shujun Geng, 2 Haifeng Wu, 4 Yanxin Shao, 5 Guannan Kang 6 1 Department of Science & Education, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, Shijiazhuang, People's Republic of China; 2 Department of Tuberculosis, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, Shijiazhuang, People's Republic of China; 3 Department of Ophthalmology, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, Shijiazhuang, People's Republic of China; 4 Clinical Laboratory, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, Shijiazhuang, People's Republic of China; 5 Office of Clinical Pharmacological Center, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, Shijiazhuang, People's Republic of China; 6 Department of Tuberculosis, Hebei Chest Hospital, Shijiazhuang, People's Republic of China Correspondence: Yanxin Shao, Office of Clinical Pharmacological Center, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Lung Disease, No. 372, Sheng Li North Street, Shijiazhuang, Hebei, 050041, People's Republic of China, Email Background: Tuberculosis (TB) is one of the most infectious diseases caused by Mycobacterium tuberculosis ( M. tb ), and the diagnosis of active tuberculosis (TB) and latent TB infection (LTBI) remains challenging. Methods: Gene expression files were downloaded from the GEO database to identify the differentially expressed genes (DEGs). The ssGSEA algorithm was applied to assess the immunological characteristics of patients with LTBI and TB. Weighted gene co-expression network analysis, protein-protein interaction network, and the cytoHubba plug-in of Cytoscape were used to identify the real hub genes. Finally, a diagnostic model was constructed using real hub genes and validated using a validation set. Results: Macrophages and natural killer cells were identified as important immune cells strongly associated with TB. In total, 726 mRNAs were identified as DEGs. MX1, STAT1, IFIH1, DDX58, and IRF7 were identified as real hub immune-related genes. The diagnostic model generated by the five real hub genes could distinguish active TB from healthy controls or patients with LTBI. Conclusion: Our study may provide implications for the diagnosis and drug development of M. tb infections. Keywords: tuberculosis, latent tuberculosis infection, mycobacterium tuberculosis , immune, diagnostic model Tuberculosis (TB), a chronic disease caused by Mycobacterium tuberculosis ( M. tb ), is the leading cause of death from a single infectious agent (ranking above HIV/AIDS). 1 Globally, there were 6.4 million newly diagnosed TB cases and 1.4 million deaths caused by TB in 2021. 2 The disease typically affects the lungs (pulmonary TB) but can also affect other sites (extrapulmonary TB). Indeed, approximately 90% of infected people do not display clinical symptoms and not contagious, and are in a state known as "latent TB infection" (LTBI). 3 The fine line between TB and LTBI is the presence or absence of clinical symptoms, imaging changes, and bacteriological evidence of active TB. LTBI is the reservoir of the TB epidemic. 4 Of those infected with TB, approximately 5–10% will develop TB during their lifetime. 5 The World Health Organization (WHO) "End Tuberculosis Strategy" recommended that early diagnosis and treatment of LTBI patients at a higher risk of infection was essential to effectively control TB globally. 6 The tuberculin skin test fails to distinguish patients with LTBI from those with TB and people who have received Bacillus Calmette-Guérin vaccination. 7 The lack of biomarkers to distinguish active TB from LTBI limited the progress in TB control. The latest data indicated that lack of differential diagnosis of LTBI and TB may be a potential reason for the high morbidity and mortality in countries with a high TB burden. 8 Therefore, the development of rapid, simple, and cost-effective diagnostic tests is imperative for TB control. 9 Innate immunity plays an essential role in mediating the initial host response to M. tb infections. The course of infection and disease development largely depends on the early interactions between M. tb and the host innate immune system. 10 Innate immune cells are the first to encounter M. tb , such as macrophages, dendritic cells, neutrophils, and natural killer cells. 11 Macrophages are the first immune cells to encounter M. tb and -Abstract Truncated-

Genome-wide Transcriptional Profiling Identifies Potential Signatures in Discriminating Active Tuberculosis from Latent Infection

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

Novel Biomarkers Distinguishing Active Tuberculosis From Latent Infection Identified By Gene Expression Profile Of Peripheral Blood Mononuclear Cells

Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Identifies Diagnostic Biomarkers That Distinguish Active and Latent Tuberculosis

Comprehensive identification of immuno-related transcriptional signature for active pulmonary tuberculosis by integrated analysis of array and single cell RNA-seq

Transcriptional Signatures Of Human Peripheral Blood Mononuclear Cells Can Identify The Risk Of Tuberculosis Progression From Latent Infection Among Individuals With Silicosis

Specific Cytokines Analysis Incorporating Latency-Associated Antigens Differentiates Mycobacterium tuberculosis Infection Status: An Exploratory Study

Label-Free Quantitative Proteomics Identifies Novel Plasma Biomarkers for Distinguishing Pulmonary Tuberculosis and Latent Infection

Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection

Profiling the Mrna and Mirna in Peripheral Blood Mononuclear Cells in Subjects with Active Tuberculosis

Molecular characterization of T cell receptor beta variable in the peripheral blood T cell repertoire in subjects with active tuberculosis or latent tuberculosis infection

Long Non-Coding RNA Expression in PBMCs of Patients with Active Pulmonary Tuberculosis

Distinguish active tuberculosis with an immune-related signature and molecule subtypes: a multi-cohort analysis

Activation Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells Promoting the Discrimination Between Active Tuberculosis and Latent Tuberculosis Infection

Identification of Potential Biomarkers and Related Transcription Factors in Peripheral Blood of Tuberculosis Patients.

Progress on Diagnosis and Treatment of Latent Tuberculosis Infection

Diagnostic Accuracy of a Selected Signature Gene Set That Discriminates Active Pulmonary Tuberculosis and Other Pulmonary Diseases.

Comparative Mirna Expression Profiles In Individuals With Latent And Active Tuberculosis

Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB

RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Active and Latent Mycobacterium Tuberculosis Infection.

Construction of Immune-Related Diagnostic Model for Latent Tuberculosis Infection and Active Tuberculosis